F. Matsui

912 total citations
25 papers, 819 citations indexed

About

F. Matsui is a scholar working on Analytical Chemistry, Spectroscopy and Cell Biology. According to data from OpenAlex, F. Matsui has authored 25 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Analytical Chemistry, 11 papers in Spectroscopy and 8 papers in Cell Biology. Recurrent topics in F. Matsui's work include Analytical Methods in Pharmaceuticals (15 papers), Analytical Chemistry and Chromatography (11 papers) and Proteoglycans and glycosaminoglycans research (8 papers). F. Matsui is often cited by papers focused on Analytical Methods in Pharmaceuticals (15 papers), Analytical Chemistry and Chromatography (11 papers) and Proteoglycans and glycosaminoglycans research (8 papers). F. Matsui collaborates with scholars based in Canada and Japan. F. Matsui's co-authors include Akihiko Oohira, Ritsuko Katoh‐Semba, Eiji Watanabe, Yoichi Kushima, Nobuaki Maeda, Yoshinori Kuboki, Edward G Lovering, Hiroomi Keino, Dennis V. C. Awang and S J Smith and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and Neuroscience.

In The Last Decade

F. Matsui

25 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Matsui Canada 11 524 411 301 168 96 25 819
Matthew S. Kalo United States 8 319 0.6× 447 1.1× 537 1.8× 71 0.4× 86 0.9× 8 748
Keith E. Krebs United States 12 173 0.3× 465 1.1× 172 0.6× 48 0.3× 72 0.8× 15 747
Unn Örtegren Sweden 10 345 0.7× 394 1.0× 54 0.2× 12 0.1× 27 0.3× 10 629
Takahiro Kanamori Japan 12 140 0.3× 282 0.7× 217 0.7× 4 0.0× 26 0.3× 21 634
Irene Mazzoni Canada 15 133 0.3× 348 0.8× 326 1.1× 11 0.1× 123 1.3× 23 771
Wolfgang Quitschke United States 24 216 0.4× 979 2.4× 234 0.8× 16 0.1× 72 0.8× 37 1.3k
Nadine Daniel France 8 70 0.1× 373 0.9× 230 0.8× 45 0.3× 33 0.3× 8 729
Geneva Dickens United States 14 167 0.3× 570 1.4× 381 1.3× 21 0.1× 54 0.6× 22 819
Sebastian Hogl Germany 11 155 0.3× 347 0.8× 109 0.4× 27 0.2× 25 0.3× 14 784
D J Kelleher United States 15 166 0.3× 797 1.9× 333 1.1× 20 0.1× 12 0.1× 16 952

Countries citing papers authored by F. Matsui

Since Specialization
Citations

This map shows the geographic impact of F. Matsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Matsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Matsui more than expected).

Fields of papers citing papers by F. Matsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Matsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Matsui. The network helps show where F. Matsui may publish in the future.

Co-authorship network of co-authors of F. Matsui

This figure shows the co-authorship network connecting the top 25 collaborators of F. Matsui. A scholar is included among the top collaborators of F. Matsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Matsui. F. Matsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maekawa, Ryo, Ikuko Ota, Yumiko Mihara, et al.. (2023). Combined histological and DNA methylome profiling approaches may provide insights into the pathophysiology of ovarian endometriomas. Reproductive Medicine and Biology. 22(1). e12548–e12548. 3 indexed citations
2.
Matsui, F., Takuya Shuo, Shoji YAMAUCHI, et al.. (2002). Transient expression of juvenile-type neurocan by reactive astrocytes in adult rat brains injured by kainate-induced seizures as well as surgical incision. Neuroscience. 112(4). 773–781. 38 indexed citations
3.
Watanabe, Eiji, F. Matsui, Hiroomi Keino, et al.. (1996). A membrane-bound heparan sulfate proteoglycan that is transiently expressed on growing axons in the rat brain. Journal of Neuroscience Research. 44(1). 84–96. 20 indexed citations
4.
Matsui, F., et al.. (1996). A membrane‐bound heparan sulfate proteoglycan that is transiently expressed on growing axons in the rat brain. Journal of Neuroscience Research. 44(1). 84–96. 3 indexed citations
5.
Matsui, F., et al.. (1994). Immunological identification of two proteoglycan fragments derived from neurocan, a brain-specific chondroitin sulfate proteoglycan. Neurochemistry International. 25(5). 425–431. 56 indexed citations
6.
Oohira, Akihiko, F. Matsui, Eiji Watanabe, Yoichi Kushima, & Nobuaki Maeda. (1994). Developmentally regulated expression of a brain specific species of chondroitin sulfate proteoglycan, neurocan, identified with a monoclonal antibody 1G2 in the rat cerebrum. Neuroscience. 60(1). 145–157. 157 indexed citations
7.
Oohira, Akihiko, F. Matsui, & Ritsuko Katoh‐Semba. (1991). Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. Journal of Neuroscience. 11(3). 822–827. 146 indexed citations
8.
Oohira, Akihiko, F. Matsui, & Ritsuko Katoh‐Semba. (1991). Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells.. PubMed. 11(3). 822–7. 156 indexed citations
9.
Lovering, Edward G, et al.. (1985). Determination of Hydrazine in Pharmaceuticals IV: Hydrazine and Benzylhydrazine in lsocarboxazid. Journal of Pharmaceutical Sciences. 74(1). 105–107. 8 indexed citations
10.
Matsui, F., et al.. (1984). Gas Chromatographic Method for Solvent Residues in Drug Raw Materials. Journal of Pharmaceutical Sciences. 73(11). 1664–1666. 11 indexed citations
11.
Matsui, F., et al.. (1983). Determination of Azobenzene and Hydrazobenzene in Phenylbutazone and Sulfinpyrazone Products by High-Performance Liquid Chromatography. Journal of Pharmaceutical Sciences. 72(10). 1223–1224. 7 indexed citations
12.
Matsui, F., et al.. (1983). Determination of Hydrazine in Pharmaceuticals III: Hydralazine and Isoniazid Using GLC. Journal of Pharmaceutical Sciences. 72(8). 948–951. 23 indexed citations
13.
Matsui, F., et al.. (1980). Identification of Degradation Products in a Phenylbutazone Tablet Formulation. Journal of Pharmaceutical Sciences. 69(4). 469–471. 6 indexed citations
14.
Lovering, Edward G, et al.. (1979). Stability-Indicating High-Performance Liquid Chromatographic Determination of Chlorpropamide, Tolbutamide, and Their Respective Sulfonamide Degradates. Journal of Pharmaceutical Sciences. 68(5). 577–580. 7 indexed citations
15.
Matsui, F., et al.. (1978). Stability Studies of Phenylbutazone and Phenylbutazone-Antacid Oral Formulations. Journal of Pharmaceutical Sciences. 67(5). 646–650. 8 indexed citations
16.
Matsui, F., et al.. (1975). Colorimetric Analysis of Hexachlorophene in Topical Formulations. Journal of Pharmaceutical Sciences. 64(1). 125–127. 1 indexed citations
17.
Matsui, F., et al.. (1975). Determination of Major Impurity in Chlordiazepoxide Formulations and Drug Substance. Journal of Pharmaceutical Sciences. 64(9). 1545–1547. 7 indexed citations
18.
Matsui, F., et al.. (1973). The purity of phenylbutazone raw material and solid dosage forms as monitored by gas-liquid chromatography. Journal of Chromatography A. 76(1). 141–147. 6 indexed citations
19.
Awang, Dennis V. C., et al.. (1973). Pattern of Phenylbutazone Degradation. Journal of Pharmaceutical Sciences. 62(10). 1673–1676. 24 indexed citations
20.
Matsui, F., et al.. (1967). Pharmacopeial standards and specifications for bulk drugs and solid oral dosage forms. Similarities and differences. Journal of Pharmaceutical Sciences. 56(12). 1622–1641. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026